MX2009005114A - Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus. - Google Patents

Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.

Info

Publication number
MX2009005114A
MX2009005114A MX2009005114A MX2009005114A MX2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A MX 2009005114 A MX2009005114 A MX 2009005114A
Authority
MX
Mexico
Prior art keywords
gabapentin
pregabalin
prodrugs
treating tinnitus
pregabalin prodrugs
Prior art date
Application number
MX2009005114A
Other languages
English (en)
Inventor
Noa Zerangue
Original Assignee
Xenoport Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenoport Inc filed Critical Xenoport Inc
Publication of MX2009005114A publication Critical patent/MX2009005114A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen métodos para utilizar profármacos de gabapentina y pregabalina y composiciones farmacéuticas de los mismos para tratar tinnitus, y composiciones farmacéuticas de profármacos de gabapentina o pregabalina útiles para tratar tinnitus.
MX2009005114A 2006-11-14 2007-11-13 Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus. MX2009005114A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85928306P 2006-11-14 2006-11-14
PCT/US2007/023944 WO2008060572A1 (en) 2006-11-14 2007-11-13 Use of gabapentin and pregabalin prodrugs for treating tinnitus

Publications (1)

Publication Number Publication Date
MX2009005114A true MX2009005114A (es) 2009-07-16

Family

ID=39111439

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005114A MX2009005114A (es) 2006-11-14 2007-11-13 Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.

Country Status (9)

Country Link
US (1) US20080188562A1 (es)
EP (1) EP2086530A1 (es)
CN (1) CN101616664A (es)
AU (1) AU2007319851A1 (es)
BR (1) BRPI0718754A2 (es)
CA (1) CA2669246A1 (es)
EA (1) EA200970483A1 (es)
MX (1) MX2009005114A (es)
WO (1) WO2008060572A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048917B2 (en) * 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) * 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7025745B2 (en) * 2002-10-07 2006-04-11 Advanced Cardiovascular Systems, Inc. Method of making a catheter balloon using a tapered mandrel
CA2537837A1 (en) * 2003-09-11 2005-03-24 Xenoport, Inc. Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
JP4308263B2 (ja) * 2003-10-14 2009-08-05 ゼノポート，インコーポレイティド γ−アミノ酪酸アナログの結晶形
WO2006050514A1 (en) 2004-11-04 2006-05-11 Xenoport, Inc. Gabapentin prodrug sustained release oral dosage forms
MX2007012688A (es) * 2005-04-15 2008-03-14 Synta Pharmaceuticals Corp Terapia de combinacion para el cancer con compuestos de bis(tiohidrazida) amida.
CN101652133A (zh) * 2006-12-08 2010-02-17 克塞诺波特公司 Gaba类似物的前药用于治疗疾病的用途
US20080206332A1 (en) * 2007-01-11 2008-08-28 Kidney David J Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment
NZ594648A (en) * 2009-03-03 2013-12-20 Xenoport Inc Sustained release oral dosage forms of an r-baclofen prodrug
US20110130454A1 (en) * 2009-11-24 2011-06-02 Xenoport, Inc. Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
CN105777586A (zh) * 2016-04-14 2016-07-20 安徽省逸欣铭医药科技有限公司 S（+）氨己烯酸酯衍生物及其制备方法和用途
WO2022256545A1 (en) * 2021-06-04 2022-12-08 Nevakar Injectables Inc. Injectable pregabalin formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818787B2 (en) * 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) * 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
IL162028A0 (en) * 2002-01-31 2005-11-20 Warner Lambert Co Alpha 2 delta ligands to treat tinnitus
AU2003222033A1 (en) * 2002-03-20 2003-10-08 Xenoport Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
US7662987B2 (en) * 2003-07-15 2010-02-16 Xenoport, Inc. Methods for synthesis of acyloxyalkyl compounds
CA2540247C (en) * 2003-09-25 2011-01-25 Warner-Lambert Company Llc Prodrugs of amino acids with affinity for the .alpha.2.delta.-protein

Also Published As

Publication number Publication date
US20080188562A1 (en) 2008-08-07
EA200970483A1 (ru) 2009-12-30
WO2008060572A1 (en) 2008-05-22
BRPI0718754A2 (pt) 2013-12-03
AU2007319851A1 (en) 2008-05-22
EP2086530A1 (en) 2009-08-12
CA2669246A1 (en) 2008-05-22
CN101616664A (zh) 2009-12-30

Similar Documents

Publication Publication Date Title
MX2009005114A (es) Uso de los profarmacos gabapentina y pregabalina para tratar el tinnitus.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
NO20090157L (no) Tienpyrimidiner anvendelige som modulatorer av ionekanaler
WO2007027477A3 (en) Treating vulvodynia using prodrugs of gaba analogs
MX2011011949A (es) Metodos para el tratamiento de enfermedades mediante el uso de un cambiador epimetabólico (coenzima q10).
TN2010000060A1 (en) Proteasome inhibitors
IN2012DN02018A (es)
MY160041A (en) Compositions and methods for treating parasitic infections
TN2009000292A1 (en) Formulations for cancer treatment
MX2009006466A (es) Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina.
MX342128B (es) Compuestos farmaceuticos.
PH12013502370A1 (en) Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
MX2011008340A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, dosificación farmacéutica de la misma, procesos para su preparación y usos de la misma para el control glucemico mejorado en un paciente.
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
MX2008011633A (es) Aminoquinolonas como inhibidores de gsk-3.
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
MX340484B (es) Metodo para reducir daños por quemaduras de sol en las plantas.
MXPA05010515A (es) Tratamiento o prevencion de sofocos calientes utilizando profarmacos de analogos de gaba.
WO2007027476A3 (en) Treating premature ejaculation using gabapentin and pregabalin prodrugs
WO2009009034A3 (en) Methods and compositions useful in the treatment of mucositis
EA201200428A1 (ru) Композиция и способ для лечения ожирения
MX2009003022A (es) Composiciones y metodos para tratar picaduras de medusa.
MX2009004142A (es) Metodo para prevenir o tratar sindrome metabolico.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal